Amarin Reports 2026 Third Quarter Financial Results, Achieves Positive Net Income
Amarin reported Q3 2026 revenue of $39.6 million, down 20% year-over-year, driven by a 30% decline in U.S. VASCEPA sales amid generic competition and lower net pricing. The company posted its first profitable quarter in over two years with net income of $0.2 million, as operating expenses fell 44% following its $70 million cost-savings program. Cash and short-term investments rose to $323.4 million with no debt.
Key figures
- Eps
- 0
- Revenue
- 39550000
- Revenue Yoy
- -20%
- Net income
- 245000
- Us product revenue
- 28500000
- Us ipe market share
- 47%
- Europe demand growth
- 68%
- Fcf positive quarters
- fourth consecutive
- Fy2026 cash expectation
- ~$330 million
- Operating expense change
- -44%
- Licensing royalty revenue
- 2700000
- Us product revenue change
- -30%
- Global partner demand growth
- 55%
- Cash and short term investments
- 323400000
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.